Piracetam
NERVOUS SYSTEM
Also known as: 2-Pyrrolidinoneacetamide, neuracetam, nootropil, pirazetam
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Piracetam is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1972.
- ATC code: N06BX03 (Other psychostimulants and nootropics).
- Molecular formula: C6H10N2O2; molecular weight 142.16 g/mol.
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1972-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N06BX03 | NERVOUS SYSTEM › PSYCHOANALEPTICS › PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS › Other psychostimulants and nootropics |
N06BX53 | NERVOUS SYSTEM › PSYCHOANALEPTICS › PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS › Other psychostimulants and nootropics |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Central nervous system injury | 61.5 |
| Parkinsonism | 51.8 |
| Mitochondrial toxicity | 48.9 |
| Splenic injury | 48.4 |
| Mitochondrial encephalomyopathy | 48.2 |
| Hyperchloraemia | 46.1 |
| Myoclonus | 44.4 |
| Intestinal pseudo-obstruction | 43.0 |
| Hypochromasia | 40.4 |
| Neuroleptic malignant syndrome | 38.2 |
| Product selection error | 35.0 |
| Anisocytosis | 34.7 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Piracetam is on its molecule page.
| Molecular formula | C6H10N2O2 |
|---|---|
| Molecular weight | 142.16 g/mol |
| CAS number | 7491-74-9 |
| InChIKey | GMZVRMREEHBGGF-UHFFFAOYSA-N |
| PubChem CID | 4843 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
When was Piracetam first approved?
Piracetam was first approved by the YEAR INTRODUCED in 1972.
What is the chemical formula of Piracetam?
Piracetam has the molecular formula C6H10N2O2 and a molecular weight of 142.16 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2197 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL36715 — compound record and bioactivity
- PubChem CID 4843 — chemical identifiers
- DrugBank DB09210 — drug record
- FDA UNII ZH516LNZ10 — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.